| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.768 | 7.535 | 9.829 | 8.621 | 6.880 | 12.648 |
| Total Income - EUR | - | - | - | - | 3.768 | 7.535 | 9.829 | 8.621 | 6.880 | 12.648 |
| Total Expenses - EUR | - | - | - | - | 2.330 | 6.213 | 3.714 | 3.348 | 4.147 | 7.687 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.438 | 1.322 | 6.115 | 5.273 | 2.733 | 4.960 |
| Net Profit/Loss - EUR | - | - | - | - | 1.325 | 1.106 | 5.866 | 5.048 | 2.408 | 4.692 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bioconsulting Team S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.856 |
| Current Assets | - | - | - | - | 1.614 | 2.806 | 6.377 | 6.179 | 2.903 | 5.215 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 369 | 227 | 3.853 | 0 | 2.901 |
| Cash | - | - | - | - | 1.614 | 2.437 | 6.150 | 2.326 | 2.903 | 2.314 |
| Shareholders Funds | - | - | - | - | 1.367 | 2.448 | 5.914 | 5.096 | 2.456 | 4.740 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 247 | 358 | 463 | 1.083 | 447 | 2.330 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Bioconsulting Team S.r.l.